logo

New Products And Portfolio Optimization Will Strengthen Future Prospects For Life Insurer

AN
Consensus Narrative from 10 Analysts
Published
24 Nov 24
Updated
01 May 25
Share
AnalystConsensusTarget's Fair Value
JP¥1,308.50
18.5% undervalued intrinsic discount
01 May
JP¥1,066.50
Loading
1Y
18.0%
7D
5.1%

Author's Valuation

JP¥1.3k

18.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Key Takeaways

  • Launching new products and optimizing the investment portfolio have accelerated revenue and earnings growth for Dai-ichi Life.
  • Enhanced U.S. operations and strategic acquisitions, despite initial integration costs, indicate potential revenue growth and improved sales efficiency.
  • Inflation-driven deterioration in Protective's loss ratio and the integration of ShelterPoint may reduce earnings and impact overall margins and profits.

Catalysts

About Dai-ichi Life Holdings
    Through its subsidiaries, engages in the provision of insurance products in Japan, the United States, and internationally.
What are the underlying business or industry changes driving this perspective?
  • Dai-ichi Life has launched new products that have driven a significant recovery in sales. This is likely to positively impact revenue and earnings growth.
  • International operations, specifically the acquisition of ShelterPoint by Protective, are expected to contribute to revenue, although initial integration costs may delay profit contributions, impacting future earnings positively.
  • Dai-ichi Life is experiencing a positive trend in sales representatives' numbers for the first time in three years, after addressing a previous fraud incident, which should improve sales efficiency and revenue growth.
  • The company has been strategically replacing bonds to optimize its investment portfolio, mitigating losses while generating capital gains, leading to improved net margins and potential earnings stability.
  • Using high U.S. interest rates to update annuity products, Protective has improved its performance, indicating potential revenue growth and increased profitability in its U.S. operations.

Dai-ichi Life Holdings Earnings and Revenue Growth

Dai-ichi Life Holdings Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Dai-ichi Life Holdings's revenue will grow by 3.9% annually over the next 3 years.
  • Analysts assume that profit margins will shrink from 4.4% today to 3.6% in 3 years time.
  • Analysts expect earnings to reach ¥422.3 billion (and earnings per share of ¥123.26) by about May 2028, down from ¥456.5 billion today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 12.2x on those 2028 earnings, up from 8.3x today. This future PE is greater than the current PE for the JP Insurance industry at 11.6x.
  • Analysts expect the number of shares outstanding to decline by 2.64% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 4.97%, as per the Simply Wall St company report.

Dai-ichi Life Holdings Future Earnings Per Share Growth

Dai-ichi Life Holdings Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • The initial cost of integrating ShelterPoint into Protective may lead to reduced profits over the next few years, impacting overall earnings.
  • Losses from the sale of Japanese Government Bonds (JGBs) and adjustments for foreign currency bonds could affect net margins if offsetting gains are not maintained.
  • Increased claim payments and changes to the definition of adjusted profit at TAL may influence overall profit calculations, affecting earnings.
  • Protective's asset protection business faces a deterioration in the loss ratio due to inflation, which could negatively impact revenue and margins.
  • The expected extraordinary loss from the second career special support framework in fiscal year 2024 could impact earnings, depending on participant numbers.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of ¥1308.5 for Dai-ichi Life Holdings based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ¥1500.0, and the most bearish reporting a price target of just ¥1000.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be ¥11676.6 billion, earnings will come to ¥422.3 billion, and it would be trading on a PE ratio of 12.2x, assuming you use a discount rate of 5.0%.
  • Given the current share price of ¥1024.5, the analyst price target of ¥1308.5 is 21.7% higher. Despite analysts expecting the underlying buisness to decline, they seem to believe it's more valuable than what the market thinks.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives